Dextrose Injection
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Class I — High risk. Reasonable probability of serious harm or death.
Presence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.
Cause type: Particulate / foreign matter
Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.
Clinimix 4.25/25 sulfite-free (4.25% Amino Acid in 25% Dextrose) Injection, 1000 mLCLARITY Dual Chamber Container bag, Rx only. Dist: Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015. NDC: 0338-1115-04.
Compare with the code on your package — it is the most precise check available.
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Clinimix E Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose NDC 00338-1115 |
LEUCINE 311 mg/100mL; PHENYLALANINE 238 mg/100mL; LYSINE 247 mg/100mL; METHIONINE 170 mg/100mL; ISOLEUCINE 255 mg/100mL; VALINE 247 mg/100mL; HISTIDINE 204 mg/100mL; THREONINE 179 mg/100mL; TRYPTOPHAN 77 mg/100mL; ALANINE 880 mg/100mL; GLYCINE 438 mg/100mL; ARGININE 489 mg/100mL; PROLINE 289 mg/100mL; SERINE 213 mg/100mL; TYROSINE 17 mg/100mL; SODIUM ACETATE 297 mg/100mL; POTASSIUM PHOSPHATE, DIBASIC 261 mg/100mL; MAGNESIUM CHLORIDE 51 mg/100mL; SODIUM CHLORIDE 77 mg/100mL; CALCIUM CHLORIDE 33 mg/100mL; DEXTROSE 10 g/100mL | Injection Intravenous |
Baxter Healthcare Company | Rx |
Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Presence of particulate matter: Particulates identified as fiberglass
CGMP Deviations
CGMP Deviations
Presence of Foreign Substance; metal particulates were visually observed in the tablets.
Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.
Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.
Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.